ライフサイエンスコーパス: menopausal symptom

1 ontent of isoflavones that alleviate various menopausal symptoms.

2 tions to hormone therapy who have bothersome menopausal symptoms.

3 surgical menopause, and vasomotor and other menopausal symptoms.

4 ctivity and as a dietary supplement reducing menopausal symptoms.

5 ntries use complementary therapies to manage menopausal symptoms.

6 the self-managed group on overall levels of menopausal symptoms.

7 rse effects are enhanced in older women with menopausal symptoms.

8 ) and licorice (Glycyrrhiza spec.) to manage menopausal symptoms.

9 ng and aid in developing safer therapies for menopausal symptoms.

10 n memory and mood disorders as well as other menopausal symptoms.

11 replacement therapy (HRT) for alleviation of menopausal symptoms.

12 menopause and were treated for the relief of menopausal symptoms.

13 There was no significant impact on other menopausal symptoms.

14 red in regard to the short-term treatment of menopausal symptoms.

15 atives to using estrogen therapy in treating menopausal symptoms.

16 s the efficacy of supplements in controlling menopausal symptoms.

17 east cancer survivors with treatment-induced menopausal symptoms.

18 n who are prescribed HT for the treatment of menopausal symptoms.

19 ying preventive lifestyle factors related to menopausal symptoms.

20 ve increased interest in other therapies for menopausal symptoms.

21 oestrogens show promise for the treatment of menopausal symptoms.

22 and alternative medicine (CAM) therapies for menopausal symptoms.

23 questionnaire about demographic factors and menopausal symptoms.

24 uently have significant side effects such as menopausal symptoms.

25 erved bone mineral density, and reduction of menopausal symptoms.

26 considering hormone replacement therapy for menopausal symptoms.

27 s hormone therapy for preventing or treating menopausal symptoms.

28 reatment of menopausal women with bothersome menopausal symptoms.

29 (LMICs), despite its potential to alleviate menopausal symptoms.

30 ating moderate to severe vasomotor and other menopausal symptoms.

31 ear follow-up; age at natural menopause; and menopausal symptoms.

32 SVI was not associated with menopausal symptoms.

33 Managing menopausal symptoms after cancer can be challenging, and

34 ave inadequate centralised care for managing menopausal symptoms after cancer treatment, and more inf

35 hese results show that women who have severe menopausal symptoms after ovarian cancer treatment can s

36 other SES measures, other health behaviors, menopausal symptoms, age at menopause, health insurance)

37 lack cohosh, a widely used herbal remedy for menopausal symptoms, among breast cancer patients.

38 Full hGnRH-R blockade, however, results in menopausal symptoms and affects bone mineralization, thu

39 Hops extracts are used to alleviate menopausal symptoms and as an alternative to hormone rep

40 Finally, menopausal symptoms and bone density may be favorably in

41 s promise for new interventions to alleviate menopausal symptoms and improve quality of life for wome

42 y of proven benefits, including ameliorating menopausal symptoms and improving bone health.

43 edge about reproductive health, and decrease menopausal symptoms and infertility-related distress for

44 avone-rich diets are associated with reduced menopausal symptoms and lowered risk of cancers of repro

45 t specifically target their needs related to menopausal symptoms and problems with relationships, sex

46 e-agent hormone replacement therapy to treat menopausal symptoms and reduce chronic disease risk in m

47 n overview of the questionnaires that assess menopausal symptoms and research efforts to better stand

48 When added to tamoxifen, OFS results in more menopausal symptoms and sexual dysfunction, which contri

49 dition, fatigued women were more bothered by menopausal symptoms and were somewhat more likely to hav

50 f-report measures of fatigue, sleep quality, menopausal symptoms, and coping and were administered a

51 ata included health-related quality of life, menopausal symptoms, and sexual function.

52 ct and frequency of HF/NS, overall levels of menopausal symptoms, and sleep quality.

53 acement therapy, menopausal status, baseline menopausal symptoms, and treatment.

54 omen and those soon after menopause who have menopausal symptoms-and other methods of treatment deliv

55 Menopausal symptoms are significant but are not worse th

56 supplements, consumed by women experiencing menopausal symptoms, are suggested to have positive effe

57 Age at natural menopause and self-reported menopausal symptoms based on the presence and severity o

58 proved diabetes distress, self-efficacy, and menopausal symptoms, but with impactful, costly, diabete

59 Menopausal symptoms can extend beyond hot flushes and ni

60 menopause after cancer can be challenging as menopausal symptoms can overlap with other common sympto

61 opausal women that were focused on relief of menopausal symptoms, DRSP/E2 yielded significant reducti

62 Most women worldwide experience menopausal symptoms during the menopause transition or p

63 significant improvement in overall levels of menopausal symptoms (ES, .33; P = .003), and NS frequenc

64 Black cohosh may be effective for menopausal symptoms, especially hot flashes, but the lac

65 body image (EST2 = .45; P = .009) and fewer menopausal symptoms (EST1 = .39; P = .007) than the cont

66 Women experiencing more severe menopausal symptoms exhibit poorer quality of life, and

67 ms persist as late effects (eg, infertility, menopausal symptoms, fatigue), and there may be less fre

68 < .05) related to poorer sleep quality, more menopausal symptoms, greater use of catastrophizing as a

69 of estrogen and other hormones for treating menopausal symptoms has led to demand for other options;

70 ted with estrogen and progesterone to manage menopausal symptoms have resulted in its declining use a

71 third group (no increases) experienced more menopausal symptoms (hot flashes) than did women in the

72 In women with menopausal symptoms, HRT may have specific cognitive eff

73 ve in perimenopausal women, possibly because menopausal symptoms improve, but there is no clear benef

74 fects on sexual functioning, body image, and menopausal symptoms in BCSs with a sexual dysfunction.

75 ement therapy (HRT) is widely used to manage menopausal symptoms in women and can be comprised of an

76 Hormonal breast cancer treatment increases menopausal symptoms in women.

77 She experienced menopausal symptoms including hot flashes, vaginal dryne

78 decrease and 60% to 70% of women experience menopausal symptoms, including mood disturbances.

79 y more efficacious than placebo against most menopausal symptoms, including number and intensity of h

80 istics, personal and family medical history, menopausal symptoms, information used in decision making

81 The most effective treatment for bothersome menopausal symptoms is evidence-based, menopausal hormon

82 act of oncologic treatments on fertility and menopausal symptoms is often significant for patients wi

83 than placebo; its effectiveness at reducing menopausal symptoms is similar to that of oral oestradio

84 For cancer survivors who experience menopausal symptoms, lifestyle changes may be beneficial

85 nts treated with tamoxifen plus OFS had more menopausal symptoms, lower sexual activity, and inferior

86 given available therapeutic alternatives for menopausal symptom management and chronic disease preven

87 intimacy (primary outcomes) and body image, menopausal symptoms, marital functioning, psychological

88 th breast cancer reporting treatment-induced menopausal symptoms (N=422) were randomly assigned to CB

89 gens play an important role in prevention of menopausal symptoms, osteoporosis, cancer, and heart dis

90 Worsening menopausal symptoms, pelvic floor dysfunction, and physi

91 these two interventions combined (CBT/PE) on menopausal symptoms (primary outcome), body image, sexua

92 d night sweats (HF/NS) and overall levels of menopausal symptoms (primary outcomes), sleep quality, H

93 At the final visit, they completed another menopausal symptom questionnaire.

94 ealth and quality of life for midlife women, menopausal symptoms remain substantially undertreated by

95 Worsening menopausal symptom severity (1.91, 1.64-2.23) and pelvic

96 as associated with a substantial increase in menopausal symptoms, sexual dysfunction, and diminished

97 dering hormone therapy for the management of menopausal symptoms, such as hot flashes or vaginal dryn

98 systematic reviews were included, including menopausal symptoms, surrogate endpoints, biomarkers, va

99 BCS report more frequent physical and menopausal symptoms than healthy women, yet report HRQL

100 cular disease, breast and uterine cancer and menopausal symptoms than those eating Western diets.

101 Both groups also reported improvements in menopausal symptoms that were, for the most part, not si

102 diovascular disease, autoimmune disease, and menopausal symptoms, that affect >200 million individual

103 nt of women age >/= 30 years suffered severe menopausal symptoms (three- to four-fold more frequently

104 to be a potential risk factor for vasomotor menopausal symptoms (VMSs), ie, hot flushes and night sw

105 Other menopausal symptoms were also assessed.

106 s of CAM therapies for hot flashes and other menopausal symptoms were identified; of these, 12 dealt

107 al data that young postmenopausal women with menopausal symptoms who use HT for long periods of time

108 in disease prevention; however, treatment of menopausal symptoms with low-dose estrogen remains an ap

109 of hormone therapy depend on the presence of menopausal symptoms; women without flushing had greater